您的位置: 首页 > 农业专利 > 详情页

КАТЕТЕР, В ЧАСТНОСТИ ПОСТОЯННЫЙ КАТЕТЕР, ДЛЯ ЛЕЧЕНИЯ ФУНКЦИОНАЛЬНЫХ РАССТРОЙСТВ И/ИЛИ ЗАБОЛЕВАНИЙ МОЧЕВОГО ПУЗЫРЯ И/ИЛИ ПРОСТАТЫ
专利权人:
OTTO ULLRIKH;OTTO ULL'RIKH
发明人:
OTTO ULL'RIKH,OTTO ULLRIKH,ОТТО Улльрих
申请号:
RU2014106409
公开号:
RU2570937C2
申请日:
2012.05.02
申请国别(地区):
RU
年份:
2015
代理人:
摘要:
FIELD: medicine.SUBSTANCE: invention refers to medical equipment, namely to a catheter, particularly an indwelling catheter, preferentially for treating urinary bladder and/or prostate functional disorders and/or diseases, preferentially in a combination with a radiation therapy or thereafter in prostate carcinoma, and/or a drug therapy, and/or a physical therapy of prostate and/or urinary bladder. A catheter has a catheter tube and a distal connector of the catheter. Provided is a first urine drain extending from the distal connector of the catheter to at least one outlet within a proximal end of the catheter tube. Provided is a second drug delivery passage in treating the urinary bladder extending from the distal connector of the catheter to a filling urinary bladder cylinder within the proximal end of the catheter tube. The urinary bladder cylinder is configured enclosed by the urinary bladder after catheter insertion. The urinary bladder cylinder has a permeable drug delivery wall. Provided is a third drug delivery passage in treating the prostate extending from the distal connector of the catheter to a filling prostate cylinder within the proximal end of the catheter tube. When filled, the prostate cylinder is enclosed by the prostate. The prostate cylinder has a permeable drug delivery wall.EFFECT: invention enables to conduct the treatment during a preset period of time by continuous drug delivery ensured by the permeable cylinder in the treated segment; a wall permeability of the urinary bladder cylinder makes it possible to control a drug dose delivered per a unit of time accurately.10 cl, 3 dwgИзобретение относится к медицинской технике, а именно к катетеру, в частности постоянному катетеру, предпочтительно для лечения функциональных расстройств и/или заболеваний мочевого пузыря и/или простаты, предпочтительно в сочетании с проведением или после проведения радиотерапии при карциноме простаты и/или лекарственной терапии, и/или физиотерапии простаты и/или мо
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充